Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NOMAD

Financiado

Cerrado

Network Neurodegeneration in Alzheimer s Disease

Alzheimer’s disease (AD) is a highly prevalent neurodegenerative disease associated with gradual loss of cognitive functions and brain vitality. The leading amyloid cascade hypothesis for the pathogenesis of AD states that amyloid... ver más

06/04/2017

STICHTING AMSTERDA...

270K€

Presupuesto del proyecto: 270K€

Líder del proyecto

STICHTING AMSTERDAM UMC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-04-06 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

STICHTING AMSTERDAM UMC

0.00€ | Lider

STICHTING VU

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-117656RB-I00 DESARROLLO DE NUEVAS HERRAMIENTAS DIAGNOSTICAS Y ESTRATEGIAS... 316K€ Cerrado

PSI2012-38257 INDICES DE PLASTICIDAD CEREBRAL REGIONAL COMO BIOMARCADORES... 70K€ Cerrado

CTQ2014-59544-P UNA PERSPECTIVA ATOMISTICA DE LA DETECCION, TOXICIDAD Y AGRE... 143K€ Cerrado

VASCAMY Vascular and Aymloid Predictors of Neurodegeneration and Cog... 100K€ Cerrado

PID2021-126584OA-I00 UNCOVERING COMPOUNDS WITH ABILITY TO BLOCK EARLY AMYLOID SEE... 133K€ Cerrado

ALZSYN Imaging synaptic contributors to dementia 2M€ Cerrado

Líder del proyecto

STICHTING AMSTERDAM UMC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 270K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Alzheimer’s disease (AD) is a highly prevalent neurodegenerative disease associated with gradual loss of cognitive functions and brain vitality. The leading amyloid cascade hypothesis for the pathogenesis of AD states that amyloid-β (Aβ) starts to accumulate ~15 years before symptom onset and starts a cascade of pathological events, including aggregation of tau. It is known (mainly from post-mortem and animal studies) that these proteins may cause disruptions in brain networks, neurodegeneration and eventually cognitive decline. It is unclear, however, how these processes interact in the living human brain and this incomplete understanding of disease mechanisms may partially account for the lack of successful treatment options to date. The recent advent of a novel PET tracer for tau, however, allows for the very first time in-depth testing of the amyloid cascade hypothesis in vivo. Drawing on state-of-the-art PET and MRI techniques, this project will investigate how Aβ, tau and neurodegeneration relate to each other and to brain connectivity. More specifically, it will 1) unravel spatial overlap between the AD hallmark pathologies and neurodegeneration, and 2) investigate how the brain’s functional architecture shapes vulnerability to Aβ, tau and neurodegeneration in AD. This project offers an innovative and multidisciplinary network model of neurodegeneration approach to the problem of clinical, anatomical and molecular heterogeneity in AD. By producing high-quality output and using the international networks of University of California San Francisco (outgoing host) and VU University Medical Center (return host), this fellowship will play a vital role in diversifying and consolidating the fellow’s new research line. He will be exceptionally well prepared to design and develop his own research program in AD and undertake international competitive research within the European Research Area that integrates cutting-edge neuroimaging and cognitive measures.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores